RICHA DHUNGANA: Open Payments
NPI 1922776533 · KINSTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$526 in 25 payments from 10 companies in 2025. Trend: 2023 $453 · 2024 $296 · 2025 $526
Food & beverage: $526
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 7 | $142 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $87 |
| Alexion Pharmaceuticals, Inc. | 4 | $74 |
| Janssen Biotech, Inc. | 2 | $43 |
| Incyte Corporation | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| Melinta Therapeutics, LLC | 1 | $31 |
| Stryker Corporation | 1 | $30 |
| Eisai Inc. | 1 | $22 |
| Mallinckrodt Hospital Products Inc. | 1 | $15 |
Products named: KEYTRUDA, XIFAXAN, ULTOMIRIS, DARZALEX, JARDIANCE, Rezzayo, FLOWTRIEVER, ZERBAXA.
Industry payments across NC — which companies pay providers there.
